论文部分内容阅读
目的观察培菲康治疗轮状病毒肠炎的治疗效果。方法轮状病毒肠炎患儿320例随机分为2组,对照组160例应用抗病毒、补液等常规治疗;治疗组160例在常规治疗同时给予培菲康口服。比较总有效率及不良反应。结果治疗组总有效率85.6%,对照组71.2%,差异明显(χ2=9.77,P(0.01),无不良反应。结论培菲康治疗轮状病毒肠炎简便、安全、有效,且无不良反应。
Objective To observe the therapeutic effect of Peifeikang in the treatment of rotavirus enteritis. Methods 320 cases of children with rotavirus enteritis were randomly divided into two groups, the control group of 160 cases of anti-virus, rehydration and other conventional treatment; 160 cases of the treatment group given routine treatment of Baclofan orally. Compare the total efficiency and adverse reactions. Results The total effective rate was 85.6% in the treatment group and 71.2% in the control group, with significant difference (χ2 = 9.77, P (0.01), no adverse reactions.Conclusion Pefikan treatment of rotavirus enteritis is simple, safe, effective and without adverse reactions.